Tenaya, With $92m Financing, Aims To Win In Cardiology With Three Platforms

 
• By Leah Samuel
  
rows of coins and blurred bokeh for finance and banking concept - Image
Tenaya's three-pronged approach to heart disease led to $92m series B. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business